Research ArticleOriginal Article
Open Access

Clinicopathological and prognostic significance of androgen receptor overexpression in colorectal cancer

Experience from Al-Madinah Al-Munawarah, Saudi Arabia

Abdulkader M. Albasri and Mohammed A. Elkablawy
Saudi Medical Journal September 2019, 40 (9) 893-900; DOI: https://doi.org/10.15537/smj.2019.9.24204

References

  1. ↵
    1. Davey RA,
    2. Grossmann M
    (2016) Androgen receptor structure, function and biology:from bench to bedside. Clin Biochem Rev 37:3–15.
    OpenUrlPubMed
  2. ↵
    1. Pihlajamaa P,
    2. Sahu B,
    3. Jänne OA
    (2015) Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling. Endocr Rev 36:357–384.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Modi PK,
    2. Faiena I,
    3. Kim IY
    Androgen receptor (chapter 3) Prostate cancer (second edition). Science and clinical practice 2016:21–28.
  4. ↵
    1. Hu J,
    2. Wang G,
    3. Sun T
    (2017) Dissecting the roles of the androgen receptor in prostate cancer from molecularperspectives. Tumour Biol 39:1010428317692259.
    OpenUrl
  5. ↵
    1. Lutz SZ,
    2. JörgHennenlotter J,
    3. Scharpf MO,
    4. Sailer C,
    5. Fritsche L,
    6. Schmid V
    (2018) Androgen receptor overexpression in prostate cancer in type 2 diabetes. Mol Metab 8:158–166.
    OpenUrl
  6. ↵
    1. Leach DA,
    2. Buchanan G
    (2017) Stromal androgen receptor in prostate cancer development and progression. Cancers 9:1–24.
    OpenUrlCrossRef
  7. ↵
    1. Liu YX,
    2. Zhang KJ,
    3. Tang LL
    (2018) Clinical significance of androgen receptor expression in triple negative breast cancer;an immunohistochemistry study. Oncol Lett 15:10008–10016.
    OpenUrl
  8. ↵
    1. Astvatsaturyan K,
    2. Yue Y,
    3. Walts AE,
    4. Bose S
    (2018) Androgen receptor positive triple negative breast cancer:clinicopathologic, prognostic, and predictive features. PLoS One 13:0197827.
    OpenUrl
  9. ↵
    1. Tan MH,
    2. Li J,
    3. Xu HE,
    4. Melcher K,
    5. Yong EL
    (2015) Androgen receptor:structure, role in prostate cancer and drug discovery. Acta Pharmacol Sinica 36:3–23.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Inoue S,
    2. Mizushima T,
    3. Miyamoto H
    (2018) Role of the androgen receptor in urothelial cancer. Mol Cell Endocrinol 465:73–81.
    OpenUrl
  11. ↵
    1. Mizushima T,
    2. Tirador KA,
    3. Miyamoto H
    (2017) Androgen receptor activation:a prospective therapeutic target for bladder cancer? Expert OpinTher Targets 21:249–257.
    OpenUrl
  12. ↵
    1. Kuasne H,
    2. Barros-Filho MC,
    3. Marchi FA,
    4. Drigo SA,
    5. Scapulatempo-Neto C,
    6. Faria EF
    (2018) Nuclear loss and cytoplasmic expression of androgen receptor in penile carcinomas:role as a driver event and as a prognosis factor. Virchow Archiv 473:607–614.
    OpenUrl
  13. ↵
    1. Lucas-Herald AK,
    2. Alves-Lopes R,
    3. Montezano AC,
    4. Ahmed SF,
    5. Touyz RM
    (2017) Genomic and non-genomic effects of androgens in the cardiovascular system:clinical implications. Clin Sci (Lond) 131:1405–1418.
    OpenUrl
  14. ↵
    1. Castoria G,
    2. Giovannelli P,
    3. Di Donato M,
    4. Hayashi R,
    5. Arra C,
    6. Appella E
    (2013) Targeting androgen receptor/SRC complex impairs the aggressive phenotype of human fibrosarcoma cells. PLoS One 8:76899.
    OpenUrl
  15. ↵
    1. Roshan MHK,
    2. Tambo A,
    3. Pace NP
    (2016) The role of testosterone in colorectal carcinoma:pathomechanisms and open questions. EPMA J 7:22.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Sukocheva OA,
    2. Li B,
    3. Due SL,
    4. Hussey DJ,
    5. Watson DI
    (2015) Androgens and esophageal cancer:What do we know? World J Gastroenterol 21:6146–6156.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Elkablawy MA,
    2. Albasri AM
    (2015) High quality tissue miniarray technique using a conventional TV/radio telescopic antenna. sian Pac J Cancer Prev 16:1129–1133.
    OpenUrl
  18. ↵
    1. Matsushita S,
    2. Suzuki K,
    3. Murashima A,
    4. Kajioka D,
    5. Acebedo AR,
    6. Miyagawa S,
    7. et al.
    (2018) Regulation of masculinization:androgen signalling for external genitalia development. Nat Rev Urol 15:358–368.
    OpenUrl
  19. ↵
    1. Bennett NC,
    2. Gardiner RA,
    3. Hooper JD,
    4. Johnson DW,
    5. Gobe GC
    (2010) Molecular cell biology of androgen receptor signalling. Int J Biochem Cell Biol 42:813–827.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Li P,
    2. Chen J,
    3. Miyamoto H
    (2017) Androgen receptor signaling in bladder cancer. Cancers (Basel) 9(pii):20.
    OpenUrl
    1. Kang M,
    2. Ku JH
    (2017) The role of androgen receptor signaling pathways in bladder cancer. Transl Cancer Res 6:702–707.
    OpenUrl
    1. Chen J,
    2. Cui Y,
    3. Li P,
    4. Liu L,
    5. Li C,
    6. Zu X
    (2017) Expression and clinical significance of androgen receptor in bladder cancer:A meta-analysis. Mol Clin Oncol 7:919–927.
    OpenUrl
  23. ↵
    1. Izumi K,
    2. Ito Y,
    3. Miyamoto H,
    4. Miyoshi Y,
    5. Ota J,
    6. Moriyama M,
    7. et al.
    (2016) Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence. Oncotarget 22:14153–14160.
    OpenUrl
  24. ↵
    1. Lombard AP,
    2. Mudryj M
    (2015) The emerging role of the androgen receptor in bladder cancer. Endocr Relat Cancer 22:265–277.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Chang C,
    2. Lee SO,
    3. Yeh S,
    4. Chang TM
    (2014) Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene 33:3225–3234.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Ahmed A,
    2. Ali S,
    3. Sarkar FH
    (2014) Advances in androgen receptor targeted therapy for prostate cancer. J Cell Physiol 229:271–276.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Iacopetta D,
    2. Rechoum Y,
    3. Fuqua SAW
    (2012) The role of androgen receptor in breast cancer. Drug Discov Today Dis Mech 9(1-2):19–27.
    OpenUrl
  28. ↵
    1. Safarpour D,
    2. Pakneshan S,
    3. Tavassoli FA
    (2014) Androgen receptor (AR) expression in 400 breast carcinomas:is routine AR assessment justified? Am J Cancer Res 4:353–368.
    OpenUrlPubMed
  29. ↵
    1. Choi JE,
    2. Kang SH,
    3. Lee SJ,
    4. Bae YK
    (2015) Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer. Ann Surg Oncol 22:82–89.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Gucalp A,
    2. Traina TA
    (2017) Androgen receptor:is it a promising target? Ann Surg Oncol 24:2876–2880.
    OpenUrl
  31. ↵
    1. Kono M,
    2. Fujii T,
    3. Lim B,
    4. Karuturi MS,
    5. Tripathy D,
    6. Ueno NT
    (2017) Androgen receptor function and androgen receptor-targeted therapies in breast cancer A Review. JAMA Oncol 3:1266–1273.
    OpenUrl
  32. ↵
    1. World Health Organization
    (2018) International Agency for Cancer research (IACR), Updated 2019. Cited 31 December 2018, Available from: https://www.iarc.fr/wpcontent/uploads/2018/09/pr263_E.pdf.
  33. ↵
    1. Bray F,
    2. Ferlay J,
    3. Soerjomataram I,
    4. Siegel RL,
    5. Torre LA,
    6. Jemal A
    (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Albasri A,
    2. Yosef H,
    3. Hussainy AS,
    4. Sultan SA,
    5. Alhujaily AS
    (2014) Histopathological features of colorectal cancer in Al-Madinah region of Saudi Arabia:8 years experience. Asian Pac J Cancer Prev 15:3133–3137.
    OpenUrl
  35. ↵
    1. Cancer net
    (2018) Colorectal cancer:latest research, Updated 2019. Cited 17 January 2019, Available from: https://www.cancer.net/cancer-types/colorectal-cancer/latest-research.
  36. ↵
    1. Danielsen HE,
    2. Hveem TS,
    3. Domingo E,
    4. Pradhan M,
    5. Kleppe A,
    6. Syvertsen RA
    (2018) Prognostic markers for colorectal cancer:estimating ploidy and stroma. Ann Oncol 29:616–623.
    OpenUrl
  37. ↵
    1. Alford TC,
    2. Do HM,
    3. Geelhoed GW,
    4. Tsangaris NT,
    5. Lippman ME
    (1979) Steroid hormone receptors in human colon cancers. Cancer 43:980–984.
    OpenUrlCrossRefPubMedWeb of Science
  38. ↵
    1. Mehta RG,
    2. Fricks CM,
    3. Moon RC
    (1980) Androgen receptors in chemically-induced colon carcinogenesis. Cancer 15:1085–1089.
    OpenUrl
  39. ↵
    1. Izbicki JR,
    2. Wambach G,
    3. Hamilton SR,
    4. Harnisch E,
    5. Hogenschurz R,
    6. Izbicki W,
    7. et al.
    (1986) Androgen receptors in experimentally induced colon carcinogenesis. J Cancer Res Clin Oncol 112:39–46.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Lointier P,
    2. Wildrick DM,
    3. Boman BM
    (1992) The effects of steroid hormoneson a human colon cancer cell line in vitro. Anticancer Res 12:1327–1330.
    OpenUrlPubMedWeb of Science
  41. ↵
    1. Meggouh F,
    2. Lointier P,
    3. Pezet D,
    4. Saez S
    (1991) Status of sex steroid hormone receptors in large bowel cancer. Cancer 67:1964–1970.
    OpenUrlPubMed
  42. ↵
    1. Brentani MM,
    2. Liberato MH,
    3. Macedo TM,
    4. Habr-Gama A,
    5. Laudanna AA
    (1993) Steroid receptors in Brazilian patients with large bowel cancer. Braz J Med Biol Res 26:277–284.
    OpenUrlPubMed
  43. ↵
    1. Stebbings WS,
    2. Anderson E,
    3. Puddefoot JR,
    4. Farthing MJ,
    5. Vinson GP
    (1988) A hybrid ligand method for androgen receptor measurement. J Steroid Biochem 31:181–186.
    OpenUrlPubMed
  44. ↵
    1. Gu S,
    2. Papadopoulou N,
    3. Gehring EM,
    4. Nasir O,
    5. Dimas K,
    6. Bhavsar SK,
    7. et al.
    (2009) Functional membrane androgen receptors in colon tumors trigger pro-apoptotic responses in vitro and reduce drastically tumor incidence in vivo. Mol Cancer 8:114.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Gu S,
    2. Papadopoulou N,
    3. Nasir O,
    4. Föller M,
    5. Alevizopoulos K,
    6. Lang F
    (2011) Activation of membrane androgenreceptors in colon cancer inhibits the prosurvival signals akt/bad in vitro and in vivo and blocks migration via vinculin/actin signaling. Mol Med 17:48–58.
    OpenUrlPubMed
  46. ↵
    1. Catalano MG,
    2. Pfeffer U,
    3. Raineri M,
    4. Ferro P,
    5. Curto A,
    6. Capuzzi P,
    7. et al.
    (2000) Altered expression of androgen-receptor isoforms in human colon-cancer tissues. Int J Cancer 86:325–330.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section